Statins, Aging, and Liver Health: Unraveling Age and Sex Influence on Transcriptomic Responses in MASLD
This study reveals how age and sex modulate liver transcriptomic responses to statin therapy in metabolic dysfunction-associated steatotic liver disease (MASLD), highlighting statins' potential to suppress liver aging by targeting senescence and inducing ferroptosis pathways.